GSA Capital Partners LLP Invests $1.64 Million in The Pennant Group, Inc. $PNTG
GSA Capital Partners LLP has acquired a new stake of 64,942 shares, valued at approximately $1.64 million, in The Pennant Group, Inc. during the third quarter. Other institutional investors have also adjusted their positions, resulting in high institutional ownership of 85.88%. The Pennant Group currently holds a "Moderate Buy" consensus rating from analysts with an average target price of $36.20.
Investors in Pennant Group (NASDAQ:PNTG) have seen splendid returns of 153% over the past three years
The Pennant Group, Inc. (NASDAQ:PNTG) has delivered exceptional returns to investors, with its share price soaring 153% over the past three years. This impressive stock performance is supported by a strong compound earnings per share growth of 179% annually over the same period, indicating robust underlying business progress. While recent investor sentiment suggests some caution, the company's financial health and potential for insider buying remain points of interest for future growth.
Pennant Group Inc stock hits 52-week high at 32.29 USD By Investing.com
Pennant Group Inc. (PNTG) achieved a new 52-week high of $32.29, reflecting a 21.91% price return over the past year and a market capitalization of $1.1 billion. The healthcare services provider shows strong financial health with 29.89% revenue growth and an upcoming earnings report on March 4. Analyst firms RBC Capital and Wells Fargo have reiterated "Outperform" and upgraded to "Overweight" ratings, respectively, indicating confidence in Pennant Group's growth trajectory and financial prospects.
Allianz Asset Management GmbH Sells 67,093 Shares of The Pennant Group, Inc. $PNTG
Allianz Asset Management GmbH reduced its stake in The Pennant Group (NASDAQ:PNTG) by 53% in the third quarter, selling 67,093 shares and retaining 59,555 shares valued at approximately $1.50 million. Despite this sale, analysts maintain a "Moderate Buy" rating for PNTG with an average price target of $36.20, with Truist Financial recently upgrading the stock to "Buy." The Pennant Group, which provides specialized services to the asset management industry, currently trades around $31.16 and has a market capitalization of $1.08 billion.
Investors Appear Satisfied With The Pennant Group, Inc.'s (NASDAQ:PNTG) Prospects
The Pennant Group (NASDAQ:PNTG) has a high P/E ratio of 41x compared to the broader United States market, which typically hovers around 19x. This elevated P/E is justified by the company's strong past earnings growth and a highly optimistic future outlook, with analysts forecasting 28% annual EPS growth over the next three years, significantly outpacing the market's expected 12% growth. Investors appear satisfied with these prospects, indicating confidence in Pennant Group's continued strong performance.
Pennant Announces Fourth Quarter and Year-End 2025 Earnings Release and Call
The Pennant Group, Inc. (NASDAQ: PNTG) announced it will release its fourth quarter and fiscal year 2025 financial results on Wednesday, February 25, 2026. Management will host a live webcast on Thursday, February 26, 2026, at 10:00 a.m. Mountain Time to discuss these results. Pennant is a holding company providing home health, hospice, and senior living services across 17 states through independent operating subsidiaries.
Pennant Group Announces Q4 and FY 2025 Earnings Release Date
The Pennant Group (PNTG) announced it will release its Q4 and fiscal year 2025 financial results on February 25, 2026, followed by an investor webcast on February 26, 2026, at 10:00 a.m. Mountain Time. The company, which provides home health, hospice, and senior living services across 17 states, will use these events to detail its operational achievements and discuss financial results. Investors can access financial information through the company's Investor Relations website.
The Pennant Group (NASDAQ:PNTG) Sets New 12-Month High - Time to Buy?
The Pennant Group (NASDAQ:PNTG) reached a new 52-week high of $32.29, with analysts giving it a "Moderate Buy" rating and an average price target of $36.20. The company has strong institutional ownership and low leverage, though its valuation metrics like P/E and PEG ratios are relatively high. Recent analyst activity includes upgrades from Truist and RBC, and downgrades from Zacks and Wall Street Zen.
Pennant Announces Fourth Quarter and Year-End 2025 Earnings Release and Call
The Pennant Group, Inc. (NASDAQ: PNTG) announced that it will release its fourth quarter and fiscal year 2025 financial results on Wednesday, February 25, 2026. The company will host a live webcast on Thursday, February 26, 2026, at 10:00 a.m. Mountain Time (12:00 p.m. Eastern Time) for investors to discuss the results. Pennant provides home health, hospice, and senior living services across 17 states through its independent operating subsidiaries.
The Pennant Group, Inc. Announces Webcast for Fourth Quarter and Fiscal Year 2025 Financial Results
The Pennant Group, Inc. will release its Q4 and FY 2025 financial results on February 25, 2026. A live webcast for investors to discuss these results will be held on February 26, 2026, at 10:00 a.m. Mountain Time. The company, which provides home health, hospice, and senior living services across 17 states, aims to maintain transparency with stakeholders through this event.
Home health operator Pennant schedules Q4 2025 earnings call
The Pennant Group (NASDAQ: PNTG) announced its fourth quarter and fiscal year 2025 financial results will be released on Wednesday, February 25, 2026. Management will discuss these results in a live webcast on Thursday, February 26, 2026, at 10:00 a.m. MT (12:00 p.m. ET). The webcast and related SEC Regulation G materials will be available on the company's Investor Relations website, with a replay accessible until February 26, 2027.
Do Its Financials Have Any Role To Play In Driving The Pennant Group, Inc.'s (NASDAQ:PNTG) Stock Up Recently?
Pennant Group's stock recently rose 27% over three months. The article examines whether the company's financials, specifically its Return on Equity (ROE) and earnings growth, justify this increase. Despite a lower-than-industry-average ROE of 8.7%, Pennant Group has demonstrated significant net income growth of 29% over the last five years, attributed to efficient management and high profit reinvestment.
Pennant Group Inc stock hits 52-week high at 32.29 USD
Pennant Group Inc's stock reached a new 52-week high of $32.29, reflecting a 21.91% price return over the past year and a current market capitalization of $1.1 billion. The healthcare services provider shows strong financial health with 29.89% revenue growth and is trading slightly below its Fair Value despite a high P/E ratio. Analyst firms like RBC Capital and Wells Fargo have maintained or upgraded their ratings, citing growth potential and favorable market conditions.
70,826 Shares in The Pennant Group, Inc. $PNTG Purchased by Gallagher Capital Advisors LLC
Gallagher Capital Advisors LLC recently acquired a new stake of 70,826 shares in The Pennant Group (NASDAQ: PNTG), valued at approximately $1.79 million. This purchase makes PNTG Gallagher's 27th largest holding, representing 0.20% of the company. Other institutional investors also adjusted their positions, and analysts currently maintain a "Moderate Buy" rating with a consensus target price of $36.20 for PNTG.
The Pennant Group, Inc. (PNTG) Stock Report: A Promising 21.75% Upside for Healthcare Investors
The Pennant Group, Inc. (PNTG) is presented as an attractive investment in the healthcare sector, offering home health, hospice, and senior living services with a market cap of $1.07 billion. Analysts project a 21.75% upside with an average target price of $37.50, backed by strong revenue growth (26.80%) and positive technical indicators. The company's strategy of reinvesting earnings and its diversified service offerings across 13 states position it for continued growth.
The Pennant Group, Inc. (PNTG) Stock Analysis: Analysts Predict 32.88% Upside for Healthcare Innovator
The Pennant Group, Inc. (PNTG) is a healthcare innovator in home health and senior living services, operating across 13 states. Analysts are bullish on PNTG, predicting a 32.88% upside with an average target price of $37.50, driven by an impressive 26.80% revenue growth and strong free cash flow. The company's strategy focuses on reinvestment for growth rather than dividends, presenting an appealing opportunity for growth-focused investors in the dynamic healthcare sector.
Teacher Retirement System of Texas Sells 55,705 Shares of The Pennant Group, Inc. $PNTG
The Teacher Retirement System of Texas significantly reduced its stake in The Pennant Group, selling 55,705 shares and cutting its holdings by 59.3%. Despite this, other institutional investors have increased their positions in PNTG. The company reported better-than-expected Q3 earnings and revenue, with positive FY2025 guidance, and currently holds a "Moderate Buy" consensus rating from analysts.
The Pennant Group, Inc. (NASDAQ:PNTG) Receives Average Rating of "Moderate Buy" from Analysts
The Pennant Group, Inc. (NASDAQ:PNTG) has received an average "Moderate Buy" rating from eight analysts, with six recommending a buy and two a hold, and a consensus one-year price target of $36.20. Institutional ownership stands at 85.88%, with significant increases from Ophir Asset Management and new investments from WCM and Ameriprise. The company recently surpassed quarterly earnings estimates and provided a positive FY2025 earnings per share guidance, trading with a market capitalization of approximately $955 million.
With EPS Growth And More, Pennant Group (NASDAQ:PNTG) Makes An Interesting Case
Pennant Group (NASDAQ:PNTG) has shown an impressive 9.9% EPS growth over the last year and a 30% revenue increase to US$847 million, indicating strong financial health. The company also demonstrates good insider alignment with US$51 million worth of stock owned by insiders and a modest CEO compensation of US$2.6 million, which is below the median for similarly sized companies. These factors suggest Pennant Group is an interesting investment case for those valuing growth, insider commitment, and sensible executive pay.
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Pennant Group (PNTG) and Warby Parker (WRBY)
This article provides an overview of recent analyst ratings for several healthcare companies. It highlights that Eli Lilly & Co (LLY) and Pennant Group (PNTG) received "Buy" ratings with specific price targets, while Warby Parker (WRBY) was reiterated as "Hold." The report includes details on the analysts, their success rates, and consensus price targets for each stock.
Why The Pennant Group (PNTG) Shares Are Plunging Today
Shares of The Pennant Group (PNTG) are falling today after the Centers for Medicare and Medicaid Services (CMS) proposed a surprisingly small increase of 0.09% in Medicare Advantage payments for 2027, far below the anticipated 4% to 6% bump. This news caused a broad sell-off across the healthcare sector, impacting PNTG and other major players. The stock had previously dropped three months ago due to mixed third-quarter results, where despite exceeding revenue and adjusted earnings estimates, key profitability metrics like adjusted EBITDA and operating margin disappointed investors.
Wall Street Zen Downgrades The Pennant Group (NASDAQ:PNTG) to Hold
Wall Street Zen has downgraded The Pennant Group (NASDAQ: PNTG) from a "buy" to a "hold" rating. Despite this, the consensus among analysts is still a "Moderate Buy" with an average price target of $36.20. The company recently surpassed quarterly earnings and revenue estimates and provided positive FY2025 EPS guidance, while its stock trades at around $30.53 with a P/E of 40.7.
Pennant Group Inc stock hits 52-week high at 30.46 USD
Pennant Group Inc (PNTG) stock hit a new 52-week high of $30.46, reflecting a 9.12% increase over the past year and signaling strong investor confidence despite a Q3 2025 EPS miss. Analysts from RBC Capital and Wells Fargo have maintained or upgraded their ratings, raising price targets based on the company's acquisitions and positive outlook for its home health sector.
Pennant Group Inc stock hits 52-week high at 30.46 USD
Pennant Group Inc (PNTG) stock reached a 52-week high of $30.46, reflecting a 9.12% increase over the past year and indicating strong investor confidence. This comes despite a significant Q3 2025 EPS miss, though revenue exceeded expectations. Analyst firms RBC Capital and Wells Fargo have reiterated or upgraded their ratings, raising price targets based on the company's acquisitions and home health sector prospects.
Understanding Momentum Shifts in (PNTG)
The article analyzes The Pennant Group Inc. (PNTG), indicating a neutral sentiment across all time horizons and suggesting a wait-and-see approach. It highlights a mid-channel oscillation pattern and presents three AI-generated trading strategies with specific entry, target, and stop-loss levels for different risk profiles. A notable 32.4:1 risk-reward short setup is identified, targeting a 9.8% downside.
The Pennant Group, Inc. (PNTG) Growth Potential: Analysts Forecast a Robust 29.94% Upside
The Pennant Group, Inc. (PNTG), a healthcare sector player with dual segments in Home Health & Hospice and Senior Living, is gaining significant investor attention. Analysts forecast a 29.94% upside, with an average target price of $37.50, driven by robust revenue growth of 26.80% and effective operational management. The company's strategic focus on the expanding healthcare services market, coupled with high analyst confidence, positions it as an attractive long-term investment despite not offering dividends.
Pennant Group Inc. Reports Record Revenue and Growth
The Pennant Group Inc. reported record revenue and significant growth in its latest financial results. This growth indicates strong performance across its operations. The company's focus on expansion has contributed to its increased financial success.
The Pennant Group, Inc. (NASDAQ:PNTG) Given Average Rating of "Buy" by Analysts
The Pennant Group, Inc. (NASDAQ:PNTG) has received an average "Buy" rating from analysts, with a consensus 12-month price target of $34.80. The company recently surpassed earnings estimates and provided optimistic FY2025 guidance. PNTG shows strong institutional ownership and trades with a market capitalization near $982 million.
Wasatch Micro-Cap Fund’s updates on Pennant Group (PNTG)
|The Wasatch Micro-Cap Fund recently provided an update on its position in Pennant Group (PNTG), highlighting the company's Q3 revenue growth driven by same-store admissions and new facility acquisitions. Despite strong operational performance, the stock experienced a significant decline due to lower-than-anticipated Medicaid reimbursement rates in Illinois and adjustments to Medicare rates for home health and hospice. The Fund remains optimistic about Pennant Group's long-term prospects, citing its strong financial position and growth opportunities.
Riverbridge Partners LLC Cuts Stake in The Pennant Group, Inc. $PNTG
Riverbridge Partners LLC reduced its stake in The Pennant Group, Inc. (NASDAQ:PNTG) by 8.1% in the third quarter, while other institutional investors increased their positions or initiated new ones, maintaining high institutional ownership at 85.88%. The Pennant Group recently exceeded quarterly earnings and revenue estimates and provided strong FY2025 EPS guidance, earning a consensus "Buy" rating from Wall Street analysts with an average target price of $34.80. The company's stock shows positive price performance, trading above its 50-day and 200-day moving averages, and is expected to post significant earnings per share for the current year.
RBC Capital reiterates Outperform rating on Pennant Group stock, sees 33% upside
RBC Capital has reaffirmed its Outperform rating and $39.00 price target for The Pennant Group (NASDAQ:PNTG), projecting a 33% upside. This optimistic outlook is driven by the company trading below its Fair Value, strong revenue growth from recent acquisitions, and a favorable reimbursement environment in the healthcare sector. Additionally, Pennant Group has shown impressive execution in its senior housing segment, achieving record occupancy levels.
The Pennant Group (Nasdaq: PNTG) adds pro forma results for Amedisys, UnitedHealth units
The Pennant Group (PNTG) filed an amended Form 8-K/A to include detailed financial information regarding its acquisitions of certain Amedisys and UnitedHealth home health, hospice, and palliative care units. This amendment provides audited abbreviated financial statements for the acquired entities for the year ended December 31, 2024, and unaudited statements for the six months ended June 30, 2025, along with unaudited pro forma condensed combined financial statements. The company noted that the pro forma data is illustrative and not indicative of future performance.
The Pennant Group (NASDAQ:PNTG) Sets New 52-Week High - Time to Buy?
The Pennant Group (NASDAQ:PNTG) recently hit a new 52-week high, trading as high as $30.46, with positive analyst sentiment including a consensus "Buy" rating and a $34.80 price target. The company reported strong quarterly earnings, beating estimates and providing optimistic FY2025 guidance. Institutional investors have also been increasing their positions in PNTG.
Ranger Investment Management L.P. Buys 110,175 Shares of The Pennant Group, Inc. $PNTG
Ranger Investment Management L.P. increased its holdings in The Pennant Group, Inc. by 56.6%, purchasing 110,175 additional shares to reach a total of 304,925 shares valued at approximately $9.10 million. Other institutional investors, including 8 Knots Management and Ophir Asset Management, also significantly increased their stakes. The Pennant Group (PNTG) recently surpassed EPS and revenue estimates, provided positive FY2025 guidance, and holds a "Buy" consensus rating with a target price of $34.80 from Wall Street analysts.
Boone Capital Management LLC Has $19.37 Million Stake in The Pennant Group, Inc. $PNTG
Boone Capital Management LLC reduced its stake in The Pennant Group, Inc. by 9.7% to 649,022 shares, valued at $19.37 million, representing a significant portion of its portfolio. Wall Street analysts maintain a "Buy" consensus rating for The Pennant Group with an average target price of $34.80, following the company's recent beat on quarterly earnings estimates and positive FY2025 EPS guidance.
Ophir Asset Management Pty Ltd Buys 840,642 Shares of The Pennant Group, Inc. $PNTG
Ophir Asset Management Pty Ltd significantly increased its stake in The Pennant Group, Inc. (NASDAQ:PNTG) by 403.9% in Q2, acquiring an additional 840,642 shares to own a total of 1,048,759 shares, representing about 3.03% of the company. Institutional ownership in PNTG is high at 85.88%, with positive analyst sentiment reflected in a consensus "Buy" rating and an average price target of $34.80. The company recently reported strong Q3 earnings, beating analyst estimates for EPS and revenue.
The Pennant Group, Inc. (PNTG) Just Flashed Golden Cross Signal: Do You Buy?
The Pennant Group, Inc. (PNTG) recently displayed a "golden cross" signal, where its 50-day simple moving average crossed above its 200-day simple moving average, indicating a potential bullish breakout. Coupled with a #2 (Buy) Zacks Rank and positive earnings outlook, investors might consider PNTG for future gains. The company's stock has already seen a 14.4% increase over the past four weeks.
William Blair Initiates Coverage of Pennant Group (PNTG) with Outperform Recommendation
William Blair has initiated coverage of Pennant Group (PNTG) with an Outperform recommendation. Analysts project a 21.05% upside with an average one-year price target of $35.36 per share. The report also highlights a bullish outlook based on the put/call ratio and details institutional ownership changes.
William Blair Initiates Coverage on The Pennant Group (NASDAQ:PNTG)
William Blair has initiated coverage on The Pennant Group (NASDAQ:PNTG) with an "outperform" rating, adding to a consensus "Buy" rating and an average price target of $34.80 from analysts. The company recently surpassed quarterly earnings and revenue estimates and provided positive FY2025 guidance. Institutional ownership remains high at 85.88%, with significant stake increases from firms like Provident Investment Management.
The Bull Case For Pennant Group (PNTG) Could Change Following Truist Upgrade And Medicare Rule Shift
Truist Securities recently upgraded Pennant Group (PNTG) to a "buy" rating, citing improved operating trends, strong demand for senior care, and reduced reimbursement risk due to a favorable 2026 Medicare home health rule. This, alongside smoother integration of acquired Amedisys locations, suggests enhanced operational resilience for Pennant's home health and senior living platform. While the company's future revenue is projected to reach $1.2 billion and earnings $59.3 million by 2028, leading to a fair value upside, investors remain aware of its sensitivity to future government payer decisions.
PNTG Stock: Pennant Group Upgraded to Buy, Price Target Raised to $34 - News and Statistics
Shares of The Pennant Group (PNTG), a senior living provider, rose after Truist upgraded the stock to Buy from Hold and increased the price target to $34 from $28. The stock initially gained 4.6% in morning trading before settling at a 4.1% gain. Analyst consensus maintains a Buy rating with an average target of $34.33, suggesting a potential upside of over 22%.
Why The Pennant Group (PNTG) Stock Is Trading Up Today
Shares of senior living provider The Pennant Group (NASDAQ:PNTG) climbed 4.6% after an analyst at Truist upgraded the company's stock to Buy from Hold and raised the price target from $28 to $34. This upgrade signals renewed confidence in the company's future performance and led to increased investor interest. The stock cooled slightly but remains up 4.1% from its previous close, and analysts hold a consensus 'Buy' rating with an average target of $34.33.
Pennant Group Flexes Acquisition ‘Muscle’ As It Integrates Amedisys, LHC Group Assets
The Pennant Group Inc. recently acquired home health and hospice agencies divested from the UnitedHealth Group-Amedisys deal, along with some LHC Group assets, for $187 million, across 54 locations. This acquisition represents a significant expansion for Pennant, leveraging an integration model refined with its previous Signature Healthcare at Home deal. The company emphasizes a local ownership and leadership empowerment model for integrating these new assets, facing potential challenges with "productive paranoia" and support from UnitedHealth and Amedisys.
Senior living occupancy achieves all-time high, Pennant Group CEO says
The Pennant Group reported record-breaking third-quarter results, with senior living segment revenue up 23% and both same-store and all-store occupancy reaching all-time highs of 81.8% and 80.9%, respectively. CEO Brent Guerisoli highlighted these achievements, along with a 7.4% increase in average monthly revenue per occupied room. The company continues to invest in operational leaders and has made recent strategic acquisitions to fuel growth.
Earnings call transcript: Pennant Group Q3 2025 misses EPS, stock falls
Pennant Group (PNTG) announced its Q3 2025 earnings, reporting an EPS of $0.17, significantly missing the forecast of $0.30, which led to a stock price decline of 5.76%. Despite the EPS miss, the company's revenue exceeded expectations at $229 million against a forecast of $222.72 million, showing a 26.8% year-over-year growth. The earnings call highlighted strong revenue performance driven by strategic acquisitions, particularly the UnitedHealth Amedisys deal, and provided increased full-year 2025 guidance for revenue and adjusted EPS, expecting future growth from recent integrations.
The Pennant Group, Inc. (PNTG) Tops Q3 Earnings and Revenue Estimates
The Pennant Group, Inc. (PNTG) reported Q3 earnings of $0.3 per share, exceeding the Zacks Consensus Estimate of $0.29, despite the stock losing 4.7% since the beginning of the year. The company's revenues for the quarter were $229.04 million, surpassing the estimate by 2.71%. PNTG currently holds a Zacks Rank #3 (Hold), and its industry, Medical - Outpatient and Home Healthcare, is in the top 18% of Zacks industries.
The Pennant Group, Inc. Expands Senior Living Portfolio with Acquisitions in Idaho and Wisconsin
The Pennant Group, Inc. (PNTG) announced the acquisition of two senior living communities: Twin Rivers Senior Living in Lewiston, Idaho, and the real property for Honey Creek Heights Senior Living in West Allis, Wisconsin. These acquisitions, effective November 1st and November 4th, 2025, respectively, add 190 assisted living beds to Pennant's portfolio and strengthen its presence in the Mountain West and Midwest regions. CEO Brent Guerisoli stated that these moves align with the company's disciplined growth strategy and commitment to providing high-quality, integrated senior care services.
Truist Securities reiterates Hold rating on Pennant Group stock at $28 target - Investing.com Nigeria
This article reports that Truist Securities has reiterated its Hold rating on Pennant Group stock. The firm maintained a price target of $28 for the company.
PNTG Form 4: Director adds 1,900 shares; total direct holding 31,600 - Stock Titan
A director at Pennant Group (PNTG) acquired 1,900 shares of common stock at a price of $0 on October 15, 2025. This transaction increases the director's direct beneficial ownership to 31,600 shares. The shares are scheduled to vest in three annual installments starting October 15, 2026, and is considered a routine equity award.
PNTG Form 4: Director equity grant of 1,900 shares, 38,350 owned - Stock Titan
A director at Pennant Group (PNTG) was granted 1,900 shares of common stock on October 15, 2025, categorized as an award rather than an open-market purchase, with a vesting schedule over three annual installments starting October 15, 2026. Following this grant, the director, Stephen M.R. Covey, directly owns a total of 38,350 shares. This transaction was reported on a Form 4 filing with the SEC, indicating the director's beneficial ownership and the nature of the equity compensation.
